276 related articles for article (PubMed ID: 16931107)
21. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
22. Circulating cytokine levels in prostate cancer patients undergoing radiation therapy: influence of neoadjuvant total androgen suppression.
Johnke RM; Edwards JM; Evans MJ; Nangami GN; Bakken NT; Kilburn JM; Lee TK; Allison RR; Karlsson UL; Arastu HH
In Vivo; 2009; 23(5):827-33. PubMed ID: 19779119
[TBL] [Abstract][Full Text] [Related]
23. Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.
Yamashita H; Nishio M; Ando Y; Zhang Z; Hamaguchi M; Mita K; Kobayashi S; Fujii Y; Iwase H
Endocr Relat Cancer; 2006 Sep; 13(3):885-93. PubMed ID: 16954437
[TBL] [Abstract][Full Text] [Related]
24. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
25. Interferons in the treatment of advanced breast cancer.
Repetto L; Venturino A; Simoni C; Rosso M; Melioli G; Rosso R
J Biol Regul Homeost Agents; 1993; 7(4):109-14. PubMed ID: 7517612
[TBL] [Abstract][Full Text] [Related]
26. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
27. Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy.
Sandri MT; Johansson HA; Zorzino L; Salvatici M; Passerini R; Maisonneuve P; Rocca A; Peruzzotti G; Colleoni M
Cancer; 2007 Aug; 110(3):509-17. PubMed ID: 17559147
[TBL] [Abstract][Full Text] [Related]
28. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
[TBL] [Abstract][Full Text] [Related]
29. Optimal treatment strategies in postmenopausal women with hormone-receptor-positive and HER2-negative metastatic breast cancer.
Gligorov J; Lotz JP
Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():53-66. PubMed ID: 19101794
[TBL] [Abstract][Full Text] [Related]
30. Current immunotherapeutic strategies in breast cancer.
Carson WE; Liang MI
Surg Oncol Clin N Am; 2007 Oct; 16(4):841-60, ix. PubMed ID: 18022548
[TBL] [Abstract][Full Text] [Related]
31. [Immunotherapy in radical surgery of colorectal carcinoma].
Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
[TBL] [Abstract][Full Text] [Related]
32. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
34. Biological therapy of breast cancer: recent clinical applications.
Baar J
Curr Opin Investig Drugs; 2007 Dec; 8(12):987-95. PubMed ID: 18058569
[TBL] [Abstract][Full Text] [Related]
35. The combination of IL-21 and IFN-alpha boosts STAT3 activation, cytotoxicity and experimental tumor therapy.
Eriksen KW; Søndergaard H; Woetmann A; Krejsgaard T; Skak K; Geisler C; Wasik MA; Odum N
Mol Immunol; 2009 Feb; 46(5):812-20. PubMed ID: 18947877
[TBL] [Abstract][Full Text] [Related]
36. Changes in circulating immunosuppressive cytokine levels of cancer patients after high intensity focused ultrasound treatment.
Zhou Q; Zhu XQ; Zhang J; Xu ZL; Lu P; Wu F
Ultrasound Med Biol; 2008 Jan; 34(1):81-7. PubMed ID: 17854983
[TBL] [Abstract][Full Text] [Related]
37. Enhancing antitumor immunity: combining IL-12 with TGFbeta1 antagonism.
Fan TM; Kranz DM; Roy EJ
J Immunother; 2007; 30(5):479-89. PubMed ID: 17589288
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment.
Passam FH; Sfiridaki A; Pappa C; Kyriakou D; Petreli E; Roussou PA; Alexandrakis MG
Int J Lab Hematol; 2008 Feb; 30(1):17-25. PubMed ID: 18190463
[TBL] [Abstract][Full Text] [Related]
39. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Gnant M; Dubsky P; Fitzal F; Blaha P; Schoppmann S; Steger G; Marth C; Samonigg H; Hüttner K; Fohler H; Ruecklinger E; Jakesz R; Greil R;
Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S18-27. PubMed ID: 19561003
[TBL] [Abstract][Full Text] [Related]
40. Significance of interleukin-6 (IL-6) in breast cancer (review).
Knüpfer H; Preiss R
Breast Cancer Res Treat; 2007 Apr; 102(2):129-35. PubMed ID: 16927176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
